PMC Links for Books (Select 5506758) - PMC

Select item 101864571.

Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks

Binod Neupane, Pragya Shukla, Mahmoud Slim, Amber Martin, Michelle Petri, George K Bertsias, Alfred H J Kim, Antonis Fanouriakis, Roger A Levy, Deven Chauhan, Nick Ballew

Lupus Sci Med. 2023; 10(1): e000907. Published online 2023 May 2. doi: 10.1136/lupus-2023-000907

PMCID:: PMC10186457

Abstract Article PDF–644K

Select item 100989342.

A Randomized, Placebo‐Controlled Phase III Extension Trial of the Long‐Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus

Kenneth C. Kalunian, Richard Furie, Eric F. Morand, Ian N. Bruce, Susan Manzi, Yoshiya Tanaka, Kevin Winthrop, Ihor Hupka, Lijin (Jinny) Zhang, Shanti Werther, Gabriel Abreu, Micki Hultquist, Raj Tummala, Catharina Lindholm, Hussein Al‐Mossawi

Arthritis Rheumatol. 2023 Feb; 75(2): 253–265. Published online 2022 Nov 11. doi: 10.1002/art.42392

PMCID:: PMC10098934

Abstract Article PDF–2.4M

Select item 89215963.

Phase II randomised trial of type I interferon inhibitor anifrolumab in patients with active lupus nephritis

David Jayne, Brad Rovin, Eduardo F Mysler, Richard A Furie, Frederic A Houssiau, Teodora Trasieva, Jacob Knagenhjelm, Erik Schwetje, Yen Lin Chia, Raj Tummala, Catharina Lindholm

Ann Rheum Dis. 2022 Apr; 81(4): 496–506. Published online 2022 Feb 10. doi: 10.1136/annrheumdis-2021-221478

PMCID:: PMC8921596

Abstract Article PDF–2.6M

Select item 82520654.

Long‐Term Safety and Efficacy of Anifrolumab in Adults With Systemic Lupus Erythematosus: Results of a Phase II Open‐Label Extension Study

W. Winn Chatham, Richard Furie, Amit Saxena, Philip Brohawn, Erik Schwetje, Gabriel Abreu, Raj Tummala

Arthritis Rheumatol. 2021 May; 73(5): 816–825. Published online 2021 Mar 24. doi: 10.1002/art.41598

Correction in:: Arthritis Rheumatol. 2021 Aug; 73(8): 1570.

PMCID:: PMC8252065

Abstract Article PDF–509K

Select item 70645695.

Using the circulating proteome to assess type I interferon activity in systemic lupus erythematosus

Michael A. Smith, Chia-Chien Chiang, Kamelia Zerrouki, Saifur Rahman, Wendy I. White, Katie Streicher, William A. Rees, Adam Schiffenbauer, Lisa G. Rider, Frederick W. Miller, Zerai Manna, Sarfaraz Hasni, Mariana J. Kaplan, Richard Siegel, Dominic Sinibaldi, Miguel A. Sanjuan, Kerry A. Casey

Sci Rep. 2020; 10: 4462. Published online 2020 Mar 10. doi: 10.1038/s41598-020-60563-9

PMCID:: PMC7064569

Abstract Article PDF–5.0M

Select item 52994976.

Anifrolumab, an Anti–Interferon‐α Receptor Monoclonal Antibody, in Moderate‐to‐Severe Systemic Lupus Erythematosus

Richard Furie, Munther Khamashta, Joan T. Merrill, Victoria P. Werth, Kenneth Kalunian, Philip Brohawn, Gabor G. Illei, Jorn Drappa, Liangwei Wang, Stephen Yoo, for the CD1013 Study Investigators

Arthritis Rheumatol. 2017 Feb; 69(2): 376–386. Published online 2017 Jan 28. doi: 10.1002/art.39962

PMCID:: PMC5299497

Abstract Article PDF–463K

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from Books

Items: 6

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity